Omnipod 5 Recall: Insulin Pods May Cause High Blood Sugar | Everyday Health
Omnipod 5 Recall: Insulin Leak Risk Prompts Device Correction
Users of the Omnipod 5 insulin pump system should be aware of a voluntary medical device correction initiated by manufacturer Insulet due to a potential risk of insulin leakage. The issue centers around small tears that may develop in the internal tubing of certain Omnipod 5 pods, potentially leading to under-delivery of insulin. While the company reports no deaths linked to the issue, the potential for dangerously high blood sugar levels, including the life-threatening condition of diabetic ketoacidosis (DKA), has prompted the recall.
The recall affects approximately 1.5 percent of Omnipod 5 pods produced globally each year, according to Insulet. To date, the company has received 18 reports of adverse events, including cases of DKA and hospitalizations, related to the potential for insufficient insulin delivery. Insulin pumps are critical medical devices for people with diabetes, and consistent insulin delivery is essential for managing blood glucose levels.
Identifying Affected Pods: Lot Numbers and Where to Check
The affected insulin pods have lot numbers beginning with “PH1U,” followed by an eight-digit number. This lot number can be found printed on the pod tray lid, the bottom of the pod itself, and on the packaging of five-pack pod boxes. However, Insulet emphasizes that not all lots beginning with “PH1U” are subject to the recall.
Users are directed to check their specific lot numbers on the Omnipod website to determine if their pods are included in the voluntary correction. Pods with lot numbers not starting with “PH1U” are considered safe to leverage and are not affected by this recall. This recall does not impact continuous glucose monitors (CGM) or the accuracy of CGM readings.
What to Do If You’re Using a Recalled Pod
If you are currently using an insulin pod identified as part of this recall, Insulet advises that you immediately remove the pod and replace it with an unaffected pod. The company is offering free replacements for recalled pods. Users can request these replacements through the Omnipod website.
Additional support is available through Insulet Product Support, which can be reached 24/7 at 800-641-2049. Live agent chat support is also available at omnipod.com/current-podders.
Understanding Diabetic Ketoacidosis (DKA)
Diabetic ketoacidosis (DKA) is a serious complication of diabetes that occurs when the body produces high levels of blood acids called ketones. This happens when the body doesn’t have enough insulin to allow blood sugar to enter cells for energy. The body begins to break down fat for fuel, producing ketones as a byproduct.
Symptoms of DKA can develop quickly and include excessive thirst, frequent urination, nausea, vomiting, abdominal pain, weakness, and shortness of breath. DKA is a medical emergency and requires immediate treatment, typically involving intravenous fluids, insulin therapy, and electrolyte replacement. Learn more about DKA from Everyday Health.
Voluntary Correction and Ongoing Monitoring
Insulet’s action is classified as a voluntary medical device correction, indicating the company initiated the recall proactively after identifying the potential issue. This differs from a mandatory recall issued by a regulatory body like the Food and Drug Administration (FDA). However, the FDA is likely to monitor the situation closely and may grab further action if deemed necessary.
The company has not released detailed information regarding the manufacturing process that led to the tubing defects. Further investigation will likely be needed to determine the root cause and prevent similar issues from occurring in the future. The recall highlights the importance of robust quality control measures in the manufacturing of medical devices, particularly those critical for life-sustaining therapies.
What This Means for Omnipod 5 Users
For individuals relying on the Omnipod 5 system, this recall underscores the importance of vigilance and proactive device monitoring. Regularly checking pod lot numbers and promptly replacing any affected pods is crucial. While the percentage of affected pods is relatively small, the potential consequences of insulin under-delivery are significant.
It’s also a reminder to maintain open communication with healthcare providers. Individuals using the Omnipod 5 system should discuss any concerns or questions they have with their doctors or diabetes educators. Staying informed about device updates and potential safety issues is an essential part of managing diabetes effectively.
Staying Informed and Seeking Support
Users can find the most up-to-date information about the recall, including a tool to check their pod lot numbers, on the official Omnipod website: https://www.omnipod.com/mdc-3-26/check-pod-lot. Insulet’s product support team remains available to answer questions and facilitate pod replacements. For those seeking additional information about diabetes management and DKA, resources are available from organizations like the American Diabetes Association (https://www.diabetes.org/) and the JDRF (https://www.jdrf.org/).